베바시주맙 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "베바시주맙" in Korean language version.

refsWebsite

Global rank Korean rank

1^st place

2^nd place

3^rd place

4^th place

195^th place

98^th place

399^th place

141^st place

low place

2,329^th place

doi.org

Los M, Roodhart JM, Voest EE (April 2007). “Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer”. 《The Oncologist》 12 (4): 443–50. doi:10.1634/theoncologist.12-4-443. PMID 17470687.
Karpinska A, Magiera G, Kwapiszewska K, Hołyst R (2023). “Cellular Uptake of Bevacizumab in Cervical and Breast Cancer Cells Revealed by Single-Molecule Spectroscopy”. 《Journal of Physical Chemistry Letters》 14 (5): 1272–1278. doi:10.1021/acs.jpclett.2c03590. PMC 9923738. PMID 36719904.
Shih T, Lindley C (November 2006). “Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies”. 《Clinical Therapeutics》 28 (11): 1779–802. doi:10.1016/j.clinthera.2006.11.015. PMID 17212999.

“Bevacizumab”. The American Society of Health-System Pharmacists. 20 December 2016에 원본 문서에서 보존된 문서. 8 December 2016에 확인함.

“Bevacizumab”. 《International Drug Price Indicator Guide》. 2018년 10월 22일에 원본 문서에서 보존된 문서. 2016년 12월 8일에 확인함.

Los M, Roodhart JM, Voest EE (April 2007). “Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer”. 《The Oncologist》 12 (4): 443–50. doi:10.1634/theoncologist.12-4-443. PMID 17470687.
Karpinska A, Magiera G, Kwapiszewska K, Hołyst R (2023). “Cellular Uptake of Bevacizumab in Cervical and Breast Cancer Cells Revealed by Single-Molecule Spectroscopy”. 《Journal of Physical Chemistry Letters》 14 (5): 1272–1278. doi:10.1021/acs.jpclett.2c03590. PMC 9923738. PMID 36719904.
Shih T, Lindley C (November 2006). “Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies”. 《Clinical Therapeutics》 28 (11): 1779–802. doi:10.1016/j.clinthera.2006.11.015. PMID 17212999.

“Bevacizumab”. The American Society of Health-System Pharmacists. 20 December 2016에 원본 문서에서 보존된 문서. 8 December 2016에 확인함.
“WHO Model List of Essential Medicines (19th List)” (PDF). 《World Health Organization》. April 2015. 13 December 2016에 원본 문서 (PDF)에서 보존된 문서. 8 December 2016에 확인함.
“WHO Model List of EssentialMedicines” (PDF). 《World Health Organization》. October 2013. 23 April 2014에 원본 문서 (PDF)에서 보존된 문서. 22 April 2014에 확인함.
“Bevacizumab”. 《International Drug Price Indicator Guide》. 2018년 10월 22일에 원본 문서에서 보존된 문서. 2016년 12월 8일에 확인함.

“WHO Model List of Essential Medicines (19th List)” (PDF). 《World Health Organization》. April 2015. 13 December 2016에 원본 문서 (PDF)에서 보존된 문서. 8 December 2016에 확인함.

“WHO Model List of EssentialMedicines” (PDF). 《World Health Organization》. October 2013. 23 April 2014에 원본 문서 (PDF)에서 보존된 문서. 22 April 2014에 확인함.